PURPOSE: To create an in vivo model of vector-mediated trabecular meshwork (TM) ablation and replacement. METHODS: We generated a conditionally cytotoxic, trackable vector, HSVtkiG, that expressed herpes simplex virus 1 thymidine kinase (HSVtk) and enhanced green fluorescent protein (eGFP). We optimized HSVtkiG ablation in vitro with ganciclovir (GCV) in comparison to eGFP control vector GINSIN and investigated the mechanism. Right eyes of 24 rats were then injected intracamerally with either HSVtkiG or GINSIN, before intraperitoneal GCV was administered 1 week later. Intraocular pressure, central corneal thickness (CCT), and slit-lamp exams were assessed for 8 weeks. Transduction and ablation were followed by gonioscopic visualization of eGFP. Histology was obtained with TM cell counts and immunohistochemistry markers of inflammation. RESULTS: Transduction and ablation parameters were established in vitro. Apoptosis was the cause of cell death. In vivo, transduction was seen gonioscopically to be targeted to the TM, followed by disappearance of eGFP marker fluorescence in HSVtkiG-transduced cells after injection of GCV. Ablation resulted in an IOP decrease of 25% in HSVtkiG-injected eyes 2 days after GCV but not in GINSIN or noninjected control eyes (P < 0.05). Trabecular meshwork cellularity was decreased at the time of lowest IOP and recovered thereafter, while CCT remained unchanged. Inflammation was absent. CONCLUSIONS: A vector-based system for inducible ablation of cells of the outflow tract was developed. Trabecular meshwork ablation lowered IOP, and recovery of cellularity and IOP followed. This model may be useful to study pressure regulation by the TM, its stem cells, and migration patterns.
PURPOSE: To create an in vivo model of vector-mediated trabecular meshwork (TM) ablation and replacement. METHODS: We generated a conditionally cytotoxic, trackable vector, HSVtkiG, that expressed herpes simplex virus 1 thymidine kinase (HSVtk) and enhanced green fluorescent protein (eGFP). We optimized HSVtkiG ablation in vitro with ganciclovir (GCV) in comparison to eGFP control vector GINSIN and investigated the mechanism. Right eyes of 24 rats were then injected intracamerally with either HSVtkiG or GINSIN, before intraperitoneal GCV was administered 1 week later. Intraocular pressure, central corneal thickness (CCT), and slit-lamp exams were assessed for 8 weeks. Transduction and ablation were followed by gonioscopic visualization of eGFP. Histology was obtained with TM cell counts and immunohistochemistry markers of inflammation. RESULTS: Transduction and ablation parameters were established in vitro. Apoptosis was the cause of cell death. In vivo, transduction was seen gonioscopically to be targeted to the TM, followed by disappearance of eGFP marker fluorescence in HSVtkiG-transduced cells after injection of GCV. Ablation resulted in an IOP decrease of 25% in HSVtkiG-injected eyes 2 days after GCV but not in GINSIN or noninjected control eyes (P < 0.05). Trabecular meshwork cellularity was decreased at the time of lowest IOP and recovered thereafter, while CCT remained unchanged. Inflammation was absent. CONCLUSIONS: A vector-based system for inducible ablation of cells of the outflow tract was developed. Trabecular meshwork ablation lowered IOP, and recovery of cellularity and IOP followed. This model may be useful to study pressure regulation by the TM, its stem cells, and migration patterns.
Authors: E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield Journal: Science Date: 1997-01-31 Impact factor: 47.728
Authors: Pranay D Khare; Nils Loewen; Wulin Teo; Román A Barraza; Dyana T Saenz; Douglas H Johnson; Eric M Poeschla Journal: Mol Ther Date: 2007-10-02 Impact factor: 11.454
Authors: Sara J Coulon; Joel S Schuman; Yiqin Du; Mohammad Reza Bahrani Fard; C Ross Ethier; W Daniel Stamer Journal: Prog Retin Eye Res Date: 2022-04-06 Impact factor: 19.704
Authors: Yalong Dang; Susannah Waxman; Chao Wang; Adrianna Jensen; Ralitsa T Loewen; Richard A Bilonick; Nils A Loewen Journal: PeerJ Date: 2017-08-14 Impact factor: 2.984
Authors: Barbara Bogner; Sanford L Boye; Seok Hong Min; James J Peterson; Qing Ruan; Zhonghong Zhang; Herbert A Reitsamer; William W Hauswirth; Shannon E Boye Journal: PLoS One Date: 2015-06-08 Impact factor: 3.240
Authors: Ralitsa T Loewen; Pritha Roy; Daniel B Park; Adrianna Jensen; Gordon Scott; Devora Cohen-Karni; Michael P Fautsch; Joel S Schuman; Nils A Loewen Journal: Invest Ophthalmol Vis Sci Date: 2016-03 Impact factor: 4.799